Abstract:Ferroptosis is a recently recognized form of regulated cell death. It is characterized morphologically by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. It can be induced by experimental compounds (e.g., erastin, Ras-selective lethal small molecule 3, and buthionine sulfoximine) or clinical drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells). Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis. This process is characterized by the accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism and can be pharmacologically inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidation inhibitors (e.g., ferrostatin, liproxstatin, and zileuton). Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as negative regulators of ferroptosis by limiting ROS production and reducing cellular iron uptake, respectively. In contrast, NADPH oxidase and p53 (especially acetylation-defective mutant p53) act as positive regulators of ferroptosis by promotion of ROS production and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), respectively. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity. In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.

Ferroptosis Regulated by Hypoxia in Cells

The Emerging Role of Ferroptosis in Cardiovascular Diseases.

Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases

Ferroptosis: Iron-mediated cell death linked to disease pathogenesis

Ferroptosis: process and function

Multifaceted Role of Ferroptosis in Cardiovascular Disease

Ferroptosis: principles and significance in health and disease

Ferroptosis and Its Role in Chronic Diseases

Ferroptosis in life: To be or not to be

Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Ferroptosis: past, present and future

Ferroptosis: mechanisms and links with diseases

Role of Ferroptosis in Lung Diseases

Ferroptosis: Regulatory mechanisms and potential targets for bone metabolism: A review

Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases

The mechanism of ferroptosis and its related diseases

Iron Metabolism in Ferroptosis

The Application of Ferroptosis in Diseases

Important molecular mechanisms in ferroptosis

Ferroptosis and Liver Fibrosis